InsiderPulseNo transactions found.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Product sales, net | $9.0M+4.0% | $8.6M-12.2% | $9.8M+11.6% | $8.8M-14.5% | $10.3M |
| Cost of products sold | $2.6M+16.9% | $2.2M-27.7% | $3.0M-22.3% | $3.9M-2.2% | $4.0M |
| Gross profit | $6.4M-0.4% | $6.4M-5.3% | $6.8M+38.6% | $4.9M-22.4% | $6.3M |
| Selling, general and administrative expenses | $11.6M-5.8% | $12.3M-6.4% | $13.1M+5.0% | $12.5M-1.8% | $12.7M |
| Research and development expenses | $449K-47.7% | $859K+22.4% | $701K-39.0% | $1.2M+31.0% | $878K |
| Depreciation and amortization expense | $78K+108.8% | $37K-39.5% | $62K-2.9% | $64K-13.7% | $74K |
| Total operating expenses | $12.1M-8.2% | $13.2M-5.1% | $13.9M+1.2% | $13.7M+0.3% | $13.7M |
| Loss from operations | -$5.7M+15.7% | -$6.8M+4.9% | -$7.1M+19.5% | -$8.8M-19.6% | -$7.4M |
| Interest (expense) income, net | -$26K-142.5% | $60K | — | — | — |
| Gain on sale of net operating losses | $2.0M | — | $0 | — | — |
| Loss before provision for income taxes | -$5.7M-21.4% | -$4.7M+32.5% | -$7.0M+20.4% | -$8.8M | — |
| Provision for income taxes | — | — | — | $0+100.0% | -$333 |
| Net loss | -$5.7M-21.4% | -$4.7M+32.5% | -$7.0M+20.4% | -$8.8M-27.6% | -$6.9M |
| Net loss per share applicable to common stockholders - basic | -$0.07-16.7% | -$0.06+40.0% | -$0.1+16.7% | -$0.12-20.0% | -$0.1 |
| Net loss per share applicable to common stockholders - diluted | -$0.07-16.7% | -$0.06 | — | — | — |
| Weighted average shares outstanding and to be issued - basic | $82.1M+2.8% | $79.8M+9.6% | $72.8M+3.1% | $70.6M+2.6% | $68.8M |
| Weighted average shares outstanding and to be issued - diluted | $82.1M+2.8% | $79.8M | — | — | $68.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...
Milestone Scientific Inc. Q1 2026 Earnings Call Summary
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript